Middle East & Africa Immunodiagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)   

Code: BMIRE00027876 | Pages: 198 | Industry: Biotechnology | Date: Jan 2023 | Type: Regional

The Middle East & Africa immunodiagnostics market is expected to grow from US$ 591.94 million in 2022 to US$ 927.14 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2022 to 2028.

 

Technological Advancements in Field of Immunodiagnostics is Fueling the Middle East & Africa Immunodiagnostics Market

 

The current trend in immunodiagnostics is microfluidics and magnetic beads with potential commercialization. These sensitive, specific, and time-saving methodologies are essential in understanding and diagnosing various health conditions, including infectious diseases, metabolic disorders, and cardiac problems. The increasing applications of immunodiagnostic solutions encouraged the development of targeted treatments and therapies for precision health. The prominent market players are also propelling the assay technology and adopting microfluidics and magnetic beads. For immunoassays, magnetic particles such as Sera-Mag beads offer a convenient alternative to plate-based ELISAs, as both rely on the same assay principle. Merck KGaA launched the Magna Chip Protein A magnetic beads. This recombinant Protein A is covalently bound to magnetic beads for chromatin immunoprecipitations (Chip assays) and provides users with a rapid, reproducible, and efficient reagent for collecting immunocomplexes than agarose beads. In microfluidics, some immunodiagnostics target single biomarkers. However, a recent trend shows that a multiple analyte detection system is required according to the complexity of the disease and the need to make early reliable diagnoses. OPKO Health's test uses microfluidics, a recent development in immunodiagnostics, to assay an array of biomarkers. On September 15, 2022, Siemens Healthineers released its new CE-marked SARS-CoV-2/FluA/FluB/HRSV assay, a PCR test, and the CLINITEST Rapid COVID-19 + Influenza Antigen Test. The new FTD SARS-CoV-2/FluA/FluB/HRSV assay enables comprehensive and semi-automated molecular testing for seasonal respiratory pathogens. The combination PCR test detects and differentiates clinically relevant viruses such as SARS-CoV-2, Influenza A, Influenza B, and HRSV A/B.

 

Middle East & Africa Overview

 

The Middle East & Africa immunodiagnostics market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Increasing usage of point-of-care diagnostics due to rising prevalence of chronic and infectious diseases such as liver and kidney diseases and emerging technologies across healthcare institutions are driving the immunodiagnostics market in the region. In Saudi Arabia, hypertension, diabetes, obesity, heart diseases, and asthma are reported as the common chronic diseases and are expected to be a major driving factor for the in-vitro diagnostics market in Saudi Arabia as immunoassay techniques are used in the diagnosis and monitoring of these diseases. For instance, according to the November 2021 report of the World Bank on the prevalence of noncommunicable diseases in Saudi Arabia, 185,500 new cases of cardiovascular disease; 303,500 new cases of chronic respiratory illness; and 2.1 million new cases of cancer were recorded. Further, as per the 2021 report of the International Diabetes Federation (IDF), the burden of diabetes in Saudi Arabia is expected to increase from 4.3 million in 2021 to 7.5 million by 2045. Further, the demand for immunoassay products is anticipated to upsurge in the country, which is expected to fuel the immunodiagnostics market in Saudi Arabia.

 

 Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

 MEA Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Middle East & Africa Immunodiagnostics Market Segmentation 

The Middle East & Africa immunodiagnostics market is segmented into product, clinical indication, end user, and country.  

 

Based on product, the Middle East & Africa immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassay (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment registered the largest market share in 2022.

 

Based on clinical indication, the Middle East & Africa immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics and others. The infectious diseases segment registered the largest market share in 2022.

 

Based on end user, the Middle East & Africa immunodiagnostics market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospital segment registered the largest market share in 2022.

 

Based on country, the Middle East & Africa immunodiagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.

 

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; Svar Life Science AB; and Thermo Fisher Scientific Inc are the leading companies operating in the Middle East & Africa immunodiagnostics market.

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Immunodiagnostics Market – By Product

1.3.2        Middle East & Africa Immunodiagnostics Market – By Clinical Indication

1.3.3        Middle East & Africa Immunodiagnostics Market – By End User

1.3.4        Middle East & Africa Immunodiagnostics Market– By Country

2.           Middle East & Africa Immunodiagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Immunodiagnostics Market– Market Landscape

4.1         Overview

4.2         Middle East & Africa PEST Analysis

4.3         Experts Opinion

5.           Middle East & Africa Immunodiagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Infectious Diseases

5.1.2        Growing Use of Point-of-Care Immunodiagnostics

5.2         Market Restraints

5.2.1        Inadequate Reimbursement Scenario

5.3         Market Opportunities

5.3.1        Rising Focus on R&D Investment and Expansion by Key Players

5.4         Future Trends

5.4.1        Technological Advancements in Immunodiagnostics

5.5         Impact Analysis

6.           Immunodiagnostics Market– Middle East & Africa Analysis

6.1         Middle East & Africa Immunodiagnostics Market Revenue Forecast and Analysis

7.           Middle East & Africa Immunodiagnostics Market Analysis – by Product

7.1         Overview

7.2         Middle East & Africa Immunodiagnostics Market, By Product, 2021 & 2028 (%)

7.3         Enzyme-linked immunosorbent assays (ELISA)

7.3.1        Overview

7.3.2        Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Chemiluminescence immunoassays (CLIA)

7.4.1        Overview

7.4.2        Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.3        Vitamin D Assay

7.4.3.1          Overview

7.4.3.2          Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.4        HIV Detection

7.4.4.1          Overview

7.4.4.2          HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.5        HIV Ag/Ab Combo assay

7.4.5.1          Overview

7.4.5.2          HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.6        Other Tests

7.4.6.1          Overview

7.4.6.2          Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Radioimmunoassays (RIA)

7.5.1        Overview

7.5.2        Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           Middle East & Africa Immunodiagnostics Market Analysis – Clinical Indication

8.1         Overview

8.2         Middle East & Africa Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)

8.3         Infectious Diseases:

8.3.1        Overview

8.3.2        Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        COVID-19

8.3.3.1          Overview

8.3.3.2          COVID-19: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Tuberculosis

8.3.4.1          Overview

8.3.4.2          Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.5        Lyme

8.3.5.1          Overview

8.3.5.2          Lyme: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.6        Infection Management

8.3.6.1          Overview

8.3.6.2          Infection Management: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.7        Zika

8.3.7.1          Overview

8.3.7.2          Zika: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.8        Treponema

8.3.8.1          Overview

8.3.8.2          Treponema: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.9        TORCH

8.3.9.1          Overview

8.3.9.2          TORCH: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.10     Middle East & Africasles and Mumps

8.3.10.1       Overview

8.3.10.2       Middle East & Africasles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.11     VZV

8.3.11.1       Overview

8.3.11.2       VZV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.12     EBV

8.3.12.1       Overview

8.3.12.2       EBV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Hepatitis+HIV:

8.4.1        Overview

8.4.2        Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         Gastrointestinal

8.5.1        Overview

8.5.2        Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6         Metabolics

8.6.1        Overview

8.6.2        Metabolics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7         Endocrinology

8.7.1        Overview

8.7.2        Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.3        Hypertension

8.7.3.1          Overview

8.7.3.2          Hypertension: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.4        Growth

8.7.4.1          Overview

8.7.4.2          Growth: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.5        Diabetes

8.7.5.1          Overview

8.7.5.2          Diabetes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.6        Thyroid

8.7.6.1          Overview

8.7.6.2          Thyroid: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.7        Reproductive Endocrinology

8.7.7.1          Overview

8.7.7.2          Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Immunodiagnostics Market Analysis – End User

9.1         Overview

9.2         Middle East & Africa Immunodiagnostics Market Share by End User - 2021 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Laboratories

9.5.1        Overview

9.5.2        Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.6         Academic and Research Institutes

9.6.1        Overview

9.6.2        Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.7         Others

9.7.1        Overview

9.7.2        Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Immunodiagnostics Market Revenue and Forecast to 2028– by Country

10.1      Overview

10.1.2     Middle East & Africa: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1       Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       Saudi Arabia Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1    Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3       Saudi Arabia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.1    Saudi Arabia Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.2    Saudi Arabia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4       Saudi Arabia: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2       South Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       South Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       South Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1    South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3       South Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.1    South Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.2    South Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4       South Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3       UAE: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       UAE: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       UAE Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1    UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3       UAE Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.1    UAE Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.2    UAE Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4       UAE Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4       Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1       Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2       Rest of Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1    Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3       Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3.1    Rest of Middle East & Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3.2    Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4       Rest of Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Global Immunodiagnostics Market –Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Abbott Laboratories

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      F. Hoffmann-La Roche Ltd

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      DiaSorin S.p.A.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Danaher Corp

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Thermo Fisher Scientific Inc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      PerkinElmer Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      bioMerieux SA

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Svar Life Science AB

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Siemens Healthineers AG

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 8.             South Africa Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 9.             South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 10.          South Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          South Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          UAE Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 15.          UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 16.          UAE Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 17.          UAE Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 18.          UAE Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 19.          UAE Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of Middle East & Africa Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Middle East & Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26.          Recent Inorganic Growth Strategies in the Immunodiagnostics Market

Table 27.          Recent Organic Growth Strategies in the Immunodiagnostics Market

Table 28.          Glossary of Terms, Middle East & Africa Immunodiagnostics Market

 

 

LIST OF FIGURES

Figure 1.           Middle East & Africa Immunodiagnostics Market Segmentation

Figure 2.           Middle East & Africa Immunodiagnostics Market Segmentation, By Country

Figure 3.           Middle East & Africa Immunodiagnostics Market Overview

Figure 4.           Middle East & Africa Immunodiagnostics Market, by Product

Figure 5.           Middle East & Africa Immunodiagnostics Market, by Country

Figure 6.           Middle East & Africa PEST Analysis

Figure 7.           Middle East & Africa Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 8.           Middle East & Africa Immunodiagnostics Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           Middle East & Africa Immunodiagnostics Market, by Product, 2021 & 2028 (%)

Figure 10.        Enzyme-linked immunosorbent assays (ELISA): Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        Chemiluminescence immunoassays (CLIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Vitamin D Assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        HIV Detection: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        HIV Ag/Ab Combo assay: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Other Tests: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Radioimmunoassays (RIA): Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Middle East & Africa Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)

Figure 19.        Infectious Diseases: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        COVID-19: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Tuberculosis: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Lyme: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Infection Management: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Zika: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Treponema: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        TORCH: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Middle East & Africasles and Mumps: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        VZV: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        EBV: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        Hepatitis+HIV: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        Gastrointestinal: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32.        Metabolics: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33.        Endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34.        Hypertension: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35.        Growth: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        Diabetes: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        Thyroid: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        Reproductive endocrinology: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40.        Middle East & Africa Immunodiagnostics Market Share by End User - 2021 & 2028 (%)

Figure 41.        Hospitals: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 42.        Clinics: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 43.        Diagnostic Laboratories: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44.        Academic and Research Institutes: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45.        Others: Middle East & Africa Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46.        Middle East & Africa: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 47.        Middle East & Africa: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

Figure 48.        Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        South Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        UAE: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.          Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

  1. Abbott Laboratories
  2. bioMerieux SA
  3. Danaher Corp
  4. DiaSorin S.p.A.
  5. F. Hoffmann-La Roche Ltd
  6. PerkinElmer Inc.
  7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  8. Siemens Healthineers AG
  9. Svar Life Science AB
  10. Thermo Fisher Scientific Inc
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000